Group 1 - The core event is the participation of the 21st batch of Chinese medical team in a diabetes public screening and health promotion activity in Guyana, organized by the Guyana Ministry of Health, which lasts for three days from November 26 to 28 [1] - The public health initiative focuses on early screening, diagnosis, and dissemination of health knowledge related to diabetes, offering services such as blood sugar testing, blood pressure measurement, and specialized consultations [2] - The involvement of the Chinese medical team enhances the professionalism and scientific nature of the event, benefiting more local residents through effective health guidance [6] Group 2 - The team leader of the Chinese medical team, Li Huan, stated that since arriving in Guyana, the team has been actively engaged in clinical services and public health initiatives, aiming to improve local healthcare services [7]

Group 1 - The event was organized to provide health care services and raise awareness about diabetes in the community, coinciding with World Diabetes Day on November 13 [1] - The event included free health screenings, health education, and interactive Q&A sessions, emphasizing community engagement and support [1][5] - The medical team from Yancheng Dexin Hospital offered free blood glucose testing, blood pressure measurement, and diabetes risk assessments, creating personalized health plans for those with abnormal results [3] Group 2 - Volunteers distributed health knowledge pamphlets to empower residents with scientific knowledge for better health management [5] - The initiative aimed to enhance residents' understanding of diabetes and improve their self-management capabilities, contributing to a healthier community [5]

Core Insights - Shanghai has significantly improved diabetes awareness and control rates among adults, reaching 61.4% and 55.0% respectively [1] - The city has registered over 2.3 million high-risk diabetes individuals and conducted screening services for over 1.1 million people [1] - Community management of diabetes patients has reached over 900,000, with a management standardization rate of nearly 95% [1] Group 1: Diabetes Management Initiatives - Shanghai is continuously optimizing diabetes prevention and treatment strategies, implementing a comprehensive service system across the city [1] - The Shanghai Health Commission has issued the "Shanghai Community Health Management Work Specification - Comprehensive Prevention and Treatment of Chronic Diseases (2025 Edition)" to enhance community health service centers' roles in diabetes management [1] Group 2: Community Health Support Centers - Over 200 out of 246 community health service centers in Shanghai have established chronic disease health management support centers, providing integrated risk assessment and screening services for various chronic diseases, including diabetes [2] Group 3: Public Awareness Campaigns - On November 14, which is the 19th United Nations Diabetes Day, Shanghai held a public awareness event focusing on diabetes prevention and management, emphasizing the importance of personal health responsibility [4] - The campaign aims to educate the public on weight management, early detection, and treatment of diabetes, as well as promoting healthy lifestyle choices [4][5]

Core Viewpoint - The article highlights the alarming increase in diabetes prevalence in China, emphasizing its significant impact on mortality and life expectancy, particularly among specific demographics such as rural populations and younger individuals [5][8][12]. Summary by Sections Diabetes Prevalence and Impact - Diabetes incidence in China surged 17 times from 0.7% in 1980 to 12.4% in 2018, with over 140 million adult patients by 2021, projected to reach 174 million by 2045 [5]. - The proportion of prediabetic individuals has reached 38.1%, indicating a growing public health concern [5]. Mortality Risks Associated with Diabetes - A study published in "Diabetes Care" revealed that diabetes patients face a 61% higher risk of all-cause mortality and a 59% increased risk of death from cardiovascular diseases (CVD) compared to those with normal blood sugar levels [6][8]. - Even prediabetic individuals experience an 8% and 10% increase in all-cause and CVD mortality risks, respectively [6]. Life Expectancy Reduction - Diagnosis of diabetes at age 40 can reduce life expectancy by approximately 4.2 years for women and 4.3 years for men [8]. - Prediabetic individuals also face a reduction in life expectancy, averaging 0.7 years for those diagnosed at 40 [8]. Cardiovascular Disease Risks - Diabetes patients have a 59% increased risk of death from CVD, with rural patients facing a 75% higher risk compared to urban counterparts [12]. - Younger patients (under 65) are at a higher risk of CVD-related mortality than older patients, with a 89% increase compared to 42% for older groups [12]. Cancer and Other Health Risks - Diabetes patients show a 31% higher overall cancer mortality rate, with specific increases of 40% for lung cancer and 134% for liver cancer [13][14]. - The study emphasizes the need for targeted prevention strategies, especially in rural areas and among younger populations [14]. Recommendations for Action - Establishing a diabetes-CVD prevention and control system in rural areas is crucial [14]. - Clinical treatments should consider the patient's location and age to enhance effectiveness [14]. - There is a strong call for increased public awareness and early screening for blood sugar abnormalities to mitigate health risks [14].

Group 1 - Astaxanthin, derived from Haematococcus pluvialis, is recognized as one of the strongest natural antioxidants and has garnered significant attention for its health benefits [1] - Research conducted by a team from Xiamen Health Medical Big Data Center indicates that astaxanthin can improve insulin resistance in type 2 diabetes mellitus (T2DM) through various mechanisms [3][4] - The study highlights that astaxanthin lowers fasting blood glucose levels and enhances insulin sensitivity while reducing inflammation by inhibiting TNF-α and IL-6 expression [3][5] Group 2 - The market for astaxanthin is experiencing robust growth, driven by multiple studies confirming its health benefits, particularly in diabetes management [7] - Green A Bio, a pioneer in the industrialization of Haematococcus pluvialis astaxanthin in China, has achieved significant breakthroughs in astaxanthin production technology and holds patents in this field [7] - The company has launched a range of high-quality products, including Red A Astaxanthin and Frozen Age Astaxanthin, which support various health benefits such as antioxidant effects, anti-inflammatory properties, and improved glucose metabolism [7] Group 3 - Diabetes, characterized by high blood sugar levels, is a chronic metabolic disease with increasing prevalence [8] - The potential of astaxanthin in diabetes prevention and treatment is becoming more evident as scientific research progresses [8] - There is optimism that astaxanthin will play a significant role in various health domains, contributing to human health advancements [8]

Core Viewpoint - The article emphasizes the critical role of artificial intelligence (AI) in managing and preventing diabetes, particularly in regions with high rates of lifestyle-related diabetes, such as the Middle East. It highlights the alarming projections of diabetes prevalence and the potential of AI technologies to provide personalized health insights and early intervention strategies [1][2]. Group 1: Diabetes Prevalence and Projections - By 2050, it is predicted that the global diabetes patient population will reach 1.3 billion, with pre-diabetic individuals potentially increasing this number to 5 billion, indicating that half of the global population may experience insulin resistance [1][2]. - The article notes that the current healthcare landscape necessitates urgent action to address the rising diabetes rates, particularly through innovative technologies [2]. Group 2: Role of AI in Diabetes Management - AI technology can assist diabetes patients in understanding food components and predicting blood sugar responses by simply taking photos of their meals [2]. - The integration of genomic data with AI can enhance predictive capabilities for diagnosing and preventing additional diseases related to diabetes, such as vision impairment and other complications [2][3]. Group 3: Collaborative Efforts in Healthcare - The collaboration between health education, AI tools, and drug development is seen as essential to mitigate the rising incidence of diabetes and improve metabolic health globally [3]. - Cigna Healthcare's CEO emphasizes that AI health monitoring technologies could potentially prevent half of the global population from developing diabetes or being pre-diabetic [2].